Antios Therapeutics is based in Doylestown, PA. It has raised $171M in total funding. Latest round: Series B.
Antios Therapeutics is based in Doylestown, PA. Antios Therapeutics has raised $171M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Antios Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include GordonMD Global Investments, EPIQ Capital Group, Arbutus Biopharma, Assembly Biosciences. 4 distinct backers are named across the disclosed rounds.
Round data for Antios Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Doylestown and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026